[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652116":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":10,"responsibleParty":32,"collaborators":10,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":10,"eligibilityCriteria":40,"healthyVolunteers":37,"sex":41,"minAge":42,"maxAge":10,"enrollmentInfo":43,"targetDuration":10,"studyType":46,"phases":10,"briefSummary":47,"conditions":48,"keywords":52,"overallStatus":56,"whyStopped":10,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":10},{"fullName":5,"class":6},"Barzilai Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Positive Procalcitonin",null,"All patients hospitalized in internal medicine and geriatric wards with a diagnosis of acute infectious disease who underwent procalcitonin testing, starting in 2020.",[13],"Other: No Interventions",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"No Interventions","No intervention, retrospective observational study",[9],[20],{"name":21,"affiliation":5,"role":22},"Daniel Leshin Carmel, MD","PRINCIPAL_INVESTIGATOR",[24,29],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Daniel Leshin Carmel Head of Infection Prevention and Control, MD","CONTACT","+972525253037","danielles@bmc.gov.il",{"name":30,"role":26,"phone":10,"phoneExt":10,"email":31},"Pnina Nir","pninan@bmc.gov.il",{"type":22,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Dr. Daniel Leshin Carmel","Head of Infection Control and Prevention Unit","100652116","procalcitonin-as-a-prognostic-predictor-in-patients-with-acute-infectious-disease-hospitalized-in-the-internal-medicine-department-100652116",false,"NCT07770334","Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.","Inclusion Criteria:\n\n* All patients hospitalized in internal medicine and geriatric wards with a diagnosis of acute infectious disease who underwent procalcitonin testing, starting in 2020.\n\nExclusion Criteria:\n\n* Age under 18\n* Causes for false positive elevated cacitonin:\n* Extensive burns\n* Major operation in the last 30 days\n* Major trauma in the last 30 days.\n* Severe pancreatitis\n* Cardiogenic shock\n* Small Cell Lung Cancer\n* Thyroid gland malignancy","ALL","18 Years",{"count":44,"type":45},1000,"ESTIMATED","OBSERVATIONAL","Procalcitonin is a well-known biomarker used to distinguish between bacterial and viral infections, assess a patient's risk category, and serve as a prognostic indicator. However, existing data are derived primarily from relatively young patients in intensive care units; there is a lack of information regarding the prognostic significance of procalcitonin in older patients hospitalized in internal medicine wards.",[49,50,51],"Procalcitonin","Infection","Internal Medicine Patients",[49,53,54,55],"CRP","Acute Infection","Internal Medicine Ward","NOT_YET_RECRUITING","2026-08-13",{"date":59,"type":60},"2026-08-18","ACTUAL",{"date":62,"type":45},"2026-09-01",{"date":64,"type":45},"2026-12-31",{"name":5,"class":6}]